These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4962660)

  • 1. [Iatrogenic Pseudomonas aeruginosa infections].
    van Beusekom JA
    Ned Tijdschr Geneeskd; 1966 Sep; 110(38):1657-8. PubMed ID: 4962660
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plan of hygiene in infection with Pseudomonas aeruginosa (B. pyocyaneum)].
    Eigenthaler G
    Osterr Krankenpflegez; 1975; 28(12):337-9. PubMed ID: 812037
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mastitis following drying up associated with teat wipes contaminated with Pseudomonas aeruginosa].
    Sol J; Barkema HW; Berghege IM; Borst GH; Hoornick LJ; Sampimon OC
    Tijdschr Diergeneeskd; 1998 Feb; 123(4):112-3. PubMed ID: 9537087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
    Cachia PJ; Hodges RS
    Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distribution in nature of types of Pseudomonas aeruginosa. I. Lysotyping of strains of Pseudomonas aeruginosa from humans and animals].
    Meitert E; Meitert T; Baron E; Sulea I
    Arch Roum Pathol Exp Microbiol; 1969 Dec; 28(4):957-64. PubMed ID: 4992009
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis.
    Kipnis E; Sawa T; Wiener-Kronish J
    Med Mal Infect; 2006 Feb; 36(2):78-91. PubMed ID: 16427231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory studies of infections due to Pseudomonas aeruginosa and Pseudomonas species.
    ERWIN CP; WAISBREN BA; KRUSE R
    Am J Med Sci; 1953 Nov; 226(5):525-32. PubMed ID: 13104404
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737
    [No Abstract]   [Full Text] [Related]  

  • 9. [When bacteria communicate with each other: the significance of intercellular signals in acute Pseudomonas aeruginosa infections].
    Van Delden C
    Rev Med Suisse Romande; 2000 Jan; 120(1):7-13. PubMed ID: 10705785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital-acquired, native valve endocarditis caused by Pseudomonas aeruginosa.
    Bicanic TA; Eykyn SJ
    J Infect; 2002 Feb; 44(2):137-9. PubMed ID: 12076074
    [No Abstract]   [Full Text] [Related]  

  • 11. [General characteristics of Pseudomonas and other related bacteria. Pathogenic ability of Pseudomonas aeruginosa].
    Cisterna Cancer R
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():3-9. PubMed ID: 9844471
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution of a Pseudomonas aeruginosa outbreak in a hematology unit with the use of disposable sterile water filters.
    Vianelli N; Giannini MB; Quarti C; Bucci Sabattini MA; Fiacchini M; de Vivo A; Graldi P; Galli S; Nanetti A; Baccarani M; Ricci P
    Haematologica; 2006 Jul; 91(7):983-5. PubMed ID: 16757413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections with Pseudomonas aeruginosa in the compromised host.
    Frøland SS
    Scand J Infect Dis Suppl; 1981; 29():72-80. PubMed ID: 6797060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of cross-infection of Pseudomonas aeruginosa in an intensive care unit].
    Lai FC; Bai YM; Mu CH; Peng DB; Zhao H
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1299-300, 1303. PubMed ID: 15567786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens].
    Shigeta S; Goto S; Ishida N
    Rinsho Byori; 1971 Jan; 19(1):77-80. PubMed ID: 4996146
    [No Abstract]   [Full Text] [Related]  

  • 16. [Trend of therapy in Pseudomonas aeruginosa infections].
    Jannuzzi C; Tassara A
    G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
    [No Abstract]   [Full Text] [Related]  

  • 17. Monovalent Pseudomonas aeruginosa vaccines in the treatment of otolaryngeal infections with Pseudomonas aeruginosa.
    Cincă D; Meitert E; Tomescu E; Meitert T; Suciu M; Sima F; Savulian C; Midan F; Lică I
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):277-84. PubMed ID: 6818930
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pseudomonas aeruginosa folliculitis after epilation].
    Trüeb RM; Elsner P; Burg G
    Hautarzt; 1993 Feb; 44(2):103-5. PubMed ID: 8449689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance of Pseudomonas aeruginosa in pediatric infections.
    Rodríguez-Morales AJ; Rodríguez CN; Garcia A; Pastran B; Jiménez I; Meijomil P
    Int J Infect Dis; 2007 Jan; 11(1):84-5. PubMed ID: 16581277
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pseudomonas aeruginosa sensitivity to boric acid, carbenicillin and deposul and their potential use in treating Pseudomonas aeruginosa infection].
    Litovchenko PP; Chernobrovyĭ NP; Shataliuk BP; Zavialets IT
    Mikrobiol Zh (1978); 1981; 43(3):369-72. PubMed ID: 6789042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.